3 studies found for:    15461622 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed GEM05 for Patients With Multiple Myeloma Under 65 Years
Condition: Multiple Myeloma
Interventions: Drug: VBMCP/VBAD/Velcade;   Drug: Thalidomide/Dexamethasone;   Drug: Velcade/Thalidomide/Dexamethasone
2 Completed GEM05 for Patients With Multiple Myeloma More Than 65 Years Old
Condition: Multiple Myeloma
Interventions: Drug: Melphalan/Prednisone/Velcade;   Drug: Thalidomide/Prednisone/Velcade
3 Completed A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma
Condition: Follicular Lymphoma
Intervention: Drug: Bortezomib and Tositumomab I-131

Indicates status has not been verified in more than two years